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Summary
Type 1 diabetes is associated with antibodies that immunoprecipitate a 64-kD islet cell membrane
protein from detergent extracts of pancreatic islets. In this study we have determined whether
mild trypsin treatment ofislet membranes can release fragments of the antigen that bind antibodies
in the serum of Type 1 diabetic patients. Partial tryptic proteolysis of [3IS)methionine-labeled
64-kD antigen immunoprecipitated from detergent extracts of rat islets resulted in the formation
of50-, 40-, and 37-kD fragments. Similar sized fragments were recovered when sera from diabetic
patients were employed to immunoprecipitate polypeptides solubilized by mild trypsin treatment
of a particulate fraction ofradiolabeled rat islets. Of 27 diabetic patients, 22 possessed antibodies
to the 50-kD polypeptide and 21 to the 40- and 37-kD polypeptides. A positive association was
found between 64k antibodies and antibodies to the 50-kD fragment but not between 64k anti-
bodies and antibodies to the 40- or 37-kD fragments. Some 64k antibody negative patients
possessed antibodies that efficiently immunoprecipitated the latter fragments. Serum from 25
of 27 (93%) diabetic patients immunoprecipitated at least one of the three tryptic polypeptides.
One of 20 nondiabetic controls immunoprecipitated a 50-kD polypeptide and all controls were
negative for antibodies to 40- and 37-kD fragments. Thus, Type 1 diabetes is associated with
the presence of at least two antibody reactivities to distinct determinants of the 64-kD antigen,
and some patients may possess antibodies to a cryptic epitope on the detergent-solubilized molecule.
These data suggest that the detection of antibodies (present in 93% of patients) to epitopes on
tryptic polypeptides of the 64-kD antigen may be of even greater diagnostic value for the onset
of Type 1 diabetes than analyses of antibodies reactive with the intact 64-kD antigen.
Insulin-dependent (Type 1) diabetes is the result of the specific
destruction of insulin-secreting a cells of the pancreatic
islet by a mechanism in which autoimmunity is implicated
(1). Studies on autoantigens associated with the disease have
identified a 0 cell-specific protein of M, 64,000 (64-kD an-
tigen) that is immunoprecipitated from detergent extracts of
islets by antibodies in the serum of diabetic patients (2-5).
Antibodiesto the 64-kD antigen (64k antibodies) are present
in -80% ofnewly diagnosed diabetic patients but are rarely
found in healthy individuals (2-4). The antibodies appear sev-
eral years before clinical onset (3), and in many patients per-
sist for as long as 0 cell function is detectable (6).
In earlier studies, enrichment of amphiphilic proteins by
phase separation in Triton X-114 detergent has been used as
a preliminary purification step before immunoprecipitation
of the 64-kD antigen (3-5). However, a significant propor-
tion ofthe protein is lost into the aqueous phase by this method
(5) . Further characterization of the 64-kD antigen, and of
immune responses to it, requires efficient procedures to ex-
tract antigen from islet cell membranes. In this studywe have
determined whether mild tryptic proteolysis might release
fragments of antigen that retain the ability to bind 64k
antibodies in patients' sera. Proteolytic treatment to release
64-kD antigen might have the additional advantage offorming
fragments that have distinct epitopes binding diabetes-
associated antibodies, allowing an analysis of heterogeneity
in immune responses to the protein between diabetic patients.
Our approach was to identify the major fragments formed
on tryptic proteolysis of purified 64-kD antigen and deter-
mine whether similar sized fragments can be recovered by
immunoprecipitation from extracts prepared by trypsin treat-
ment of islet membranes. The results demonstrate the pres-
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two distinct antibody specificities that immunoprecipitate
different tryptic fragments of the 64-kD antigen that may
include antibody reactivities to an epitope that may be hidden
on the detergent-solubilized 64-kD antigen. These data also
identify a significantly greater diagnostic potential for onset
of Type 1 diabetes by the analysis of distinct antibody
specificities for epitopes detectable on tryptic polypeptides
of 64-kD antigen compared with those on native antigen.
Materials and Methods
Subjects.
￿
Serum from a newlydiagnosed diabetic patient shown
to be strongly positive for antibodies to the 64-kD antigen (stan-
dard diabetic patient serumin reference4) was used for initial char-
acterization o£ tryptic fragments of 64-kD antigen and as a posi-
tive reference serum in subsequent antibody analyses. In addition,
sera were obtained within 10 d ofdiagnosis from 27 children (aged
6-17 yr) with Type 1 diabetes attending the Hospital for Sick Chil-
dren, Toronto. Sera from 8 normal healthy adult blood donors, 6
healthy children, and 12 children (aged 5-17 yr) attending the Hos-
pital for Sick Children with problems unrelated to diabetes served
as controls.
Islet Isolation and Labeling withr5S]Methionine.
￿
Pancreatic islets
from neonatal (5-7 d old) Wistar rats were prepared by the method
of Brundstedt et al. (7). Islets were allowed a period of recovery
of18-36 h in Hepes-buffered RPMI 1640 medium (Gibco Labora-
tories, Burlington, Ontario) containing 10% newborn calf serum
(Gibco) before labeling with [35S]methionine (Amersham, Oak-
ville, Ontario) as previouslydescribed (4). Labeled cells were stored
at -70°C.
Preparation of Islet Extracts.
￿
Labeled islets (1,000-2,000) were
homogenized on ice by 20 passes of a motor-driven Teflon/glass
homogenizer in 1 ml of0.25 M sucrose, 10 mM Hepes (pH 7.4),
0.5 MM t-methionine, 10 mM benzamidine, 0.1 mM p-chloro-
mercuriphenylsulphonic acid and 0.5% (wt/vol) aprotinin. The ho-
mogenate was centrifuged at 10,000g for 30min at 4°C. Antigens
from the particulate material in the pellet were solubilized either
by detergent extractionor by treatment of the pellet with trypsin
as described below.
For the preparation of an amphiphilic membrane protein extract,
the islet particulate fraction was extracted in 2% (wt/vol) Triton
X-114 detergent and subjected to temperature-induced phase sepa-
ration as previously described (4). The detergent phase of the frac-
tionation procedure was used in subsequent immunoprecipitations.
For trypsin treatments, the particulate fraction was resuspended
in 200 pl of 10 mM Hepes (pH 7.4), 150 mM NaCl, 0.5 mm me-
thionine,10 mM benzamidine, 0.5% aprotinin, and was centrifuged
at 10,000 g for 15 min. The pellet was resuspended in 400 Al of
10 mM Hepes (pH 7.4), 150 mM NaCl and centrifuged at 10,000
g for 15 min. The pellet was then resuspended in 10 mM Hepes
(pH 7.4), 150 mM NaCl, trypsin was added at the concentrations
indicated in the text and the suspension was incubated for 15 min
on ice. Digestion was stopped by the addition of an equal volume
of 10 mM Hepes (pH 7.4), 150 mM NaCl, 10 mm benzamidine,
0.1 mM p-chloromercuriphenylsulphonic acid and 0.5% (wt/vol)
aprotinin and the suspension was centrifuged at 10,000 g for 15
min at 4°C to remove particulate material.
Immunoprecipitation of Islet Cell Antigens by Human Sera.
￿
Pro-
tease or detergent-solubilized extracts of islets were initially pre-
cleared by incubation with 50 Al of normal human serum, nega-
tive for antibodies to the 64-kD antigen, for 2 h at 4°C followed
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by binding to 100 plofprotein A-Sepharose (Pharmacia, Baie d'Urfe,
Quebec) for 45 min at 4°C. A second preclearance was performed
with 50 A1 ofserum for 18 h at 4°C and 100 Al ofprotein A-Seph-
arose for 45 min. Extracts from 200 islets per sample in 100 Al
were incubated with 25 Al of test serum for 5 h at 4°C and im-
mune complexes were isolated on 50 Al of protein A-Sepharose.
Immunoprecipitates were washed five times in 1 ml of 10 mM Hepes
(pH 7.4), 155 mM NaCl, 0.5% Triton X-114, 10 mM benzami-
dine,0.5 mg/ml BSA, and once in 1 ml ofwater. Elution and elec-
trophoresis on 10% SDS-polyacrylamide gels were performed as
described (3). Radioactive polypeptides immunoprecipitated were
visualized by autoradiography. Antigens immunoprecipitated by
individual sera were quantified by densitometric scanning of au-
toradiogramsand standardized bycomparison with immunoprecipi-
tates from the standard human diabetic serum run in each experi-
ment (4).
Trypsin Treatment ofImmunoprecipitates.
￿
In experiments to iden-
tify tryptic fragments of the protein, immunoprecipitated 64-kD
antigen was treated with trypsin before elution and electropho-
resis. After washing ofimmunoprecipitates, the protein A-Sepharose
pellets were resuspended in 100 Al of 10 mM Hepes (pH 7.4), 150
mM NaCl, 0.5% Triton X-100, and 0.2 mg/ml trypsin and in-
cubated for 30 min at 4°C on a rotatory mixer. The protein
A-Sepharose pellets were sedimented by centrifugation and washed
in 1 ml ofwater. Matrix-bound polypeptides were eluted and ana-
lyzed by SDS-PAGE as previously described (3).
Statistical Analysis.
￿
The degree of association between antibody
activities in serum samples was tested by linear regression analysis.
Results
Identification ofTryptic Fragments ofthe 64-kD Antigen.
￿
To
analyze the major polypeptides formed on partial tryptic pro-
teolysis of the 64-kD antigen, a standard serum from a Type
1 diabetic patient previously identified as having a high ac-
tivity of 64-kD antibodies (standard diabetic serum in refer-
ence 4) was used to purify the protein from detergent ex-
tracts of neonatal rat pancreatic islets of Langerhans. The
predominant protein immunoprecipitated from Triton X-114-
detergent phase purified extracts of [ssS]methionine-labeled
rat islets by serum antibodies from this patient was the 64-
kD antigen. This protein migrated as a doublet on SDS-PAGE
(Fig. 1 a). Minor contaminating proteins in this immuno-
precipitate were also recovered when sera from normal healthy
control individuals were used and represent proteins carried
nonspecifically through the immunoprecipitation procedure
(8). The 64-kD antigen isolated as an immune complex bound
to protein A-Sepharose was incubated with trypsin (0.2
mg/ml) for 30 min at 4°C before elution and analysis by SDS-
PAGE and autoradiography. No [35S]methionine-containing
polypeptides that were specific for immunoprecipitates with
the standard diabetic patient's serum were released from the
protein A-Sepharose matrix by the trypsin treatment (results
not shown). However, subsequent elution of polypeptides
remaining bound to diabetes-associated antibodies on the ma-
trix resulted in the recovery of three major polypeptides of
50, 40, and 37 kD (Fig. 1 b). The absence of intact 64-kD
antigen after trypsin digestion indicated an efficient diges-
tion of the protein, even when bound to specific antibodies.
The polypeptides detected were not seen on trypsin treat-Figure 1 .
￿
Autoradiograms illustrating polypeptides immunoprecipi-
tated from extracts of [35S]methionine-labeled neonatal rat islet ex-
tracts by serum antibodies from a control (left lanes) or diabetic (right
lanes) individual . (a) Triton X-114 detergent phase purified proteins
were prepared from radiolabeled islets, immunoprecipitated, and ana-
lyzed by SDS-PAGE and autoradiography. (b) Immune complexes
bound to protein A-Sepharose were treated with trypsin (0.2 mg/ml)
before elution and SDS-PAGE . (c) Particulate material from radiola-
beled islets was treated with trypsin (0.5 or 5 mg/ml) and solubilized
polypeptides immunoprecipitated with control or diabetic sera . The
arrows indicate the M, of polypeptides detected .
ment of immunoprecipitates with a control serum . Thus, these
polypeptides represent the major methionine-containing frag-
ments formed on partial tryptic proteolysis of the complexed
64-kD antigen .
Serum antibodies from the same diabetic patient were used
to determine whether similar sized fragments could be re-
covered from proteins solubilized by mild trypsin treatment
of a particulate fraction of [35S]methionine-labeled rat islets.
These antibodies immunoprecipitated 50-, 40-, and 37-kD
polypeptides from extracts prepared at 0.5 mg/ml trypsin (Fig.
1 c) with electrophoretic mobilities identical to those gener-
ated by tryptic digestion of immunoprecipitated 64-kD an-
tigen. Preparation of extracts at 5 mg/ml trypsin resulted
in a reduced yield of the 50- and 37-kD polypeptides and
additional fragments of 39 (not clear on figure) and 21M
Trypsin treatment can therefore solubilize fragments ofmem-
brane-bound 64-kD antigen that retain the ability to bind
diabetes-associated antibodies.
Trypsin Concentration Dependence ofRelease ofPblypeptide Frag-
ments. Particulate fractions from [35S]methionine-labeled
islets were treated with trypsin at concentrations ranging from
0.05-5 mg/ml and the release ofthe antigenic fragments was
analyzed by immunoprecipitation with the standard diabetic
patient's serum . An estimate of quantities of antigen released
was determined by densitometric scanning of bands on au-
toradiograms corresponding to the respective polypeptides.
Optimum recovery of the 50-kD fragment was obtained at
a trypsin concentration of0.5 mg/ml, whereas peak recovery
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Trypoin concentration (mg/ml)
Figure 2 .
￿
Trypsin concentration dependence of release of antigenic
polypeptides. Particulate material from [35S]methionine-labeled islets
was treated with trypsin at the concentrations indicated and solubi-
lized polypeptides subjected to immunoprecipitation with sera from a
control or diabetic individual . Polypeptides immunoprecipitated were
analyzed by SDS-PAGE and autoradiography. The intensity of bands
on autoradiograms representing the 50-, 40-, 39-, 37-, and 21-kD
polypeptides specifically immunoprecipitated by antibodies in the dia-
betic patient's serum was quantified by densitometry.
of the 37-kD component was at 0.1 mg/ml trypsin (Fig. 2) .
Higher concentrations of trypsin resulted in reduced yields
of these two polypeptides. Recovery of the 40-kD fragment
was relatively constant throughout the range of trypsin con-
centrations employed . At higher concentrations of trypsin
(1-5 mg/ml), antibodies in the diabetic patient's serum im-
munoprecipitated additional 39- and 21-kD polypeptide
fragments .
Antibodies to 64-kD Antigen and Tryptic Fragments in Dia-
betic and Control Individuals . Analysis of the specificity of an-
tibodies to tryptic fragments of the 64-kD antigen was ex-
tended to 27 diabetic children of recent onset and 26
nondiabetic individuals . Sera from the diabetic patients were
analyzed for 64-kD antibodies by immunoprecipitation of
the protein from Triton X-114 detergent phase-purified ex-
tracts of rat islets. Antibodies to the 64-kD antigen were de-
tected in 22 (81%) of the 27 diabetic patients, a frequency
consistent with that seen in earlier studies (2-4) . For analysis
of antibodies to tryptic fragments, sera were incubated with
an extract of islets prepared using 0.5 mg/ml trypsin, im-
mune complexes were isolated on protein A-Sepharose and
analyzed by SDS-PAGE and autoradiography. The 50-, 40-,
and 37-kD polypeptides were the major polypeptides immu-
noprecipitated by the diabetic patients' sera (Fig. 3) . There
were clear differences between patients in the ability of their
antibodies to recognize the individual polypeptides ; patients
were identified that immunoprecipitated all three tryptic frag-
ments (lanes D-F), only the 40- and37-kD fragments (lanes
G, I,-]) or solely the 50-kD polypeptide (laneM . Thus, seraFigure 3 .
￿
Polypeptides immunoprecipitated from trypsin extracts of
islets by serum antibodies from control or diabetic individuals. Partic-
ulate material from [35S]methionine-labeled islets was treated with
trypsin (0 .5 mg/ml) and solubilized polypeptides were immunoprecip-
itated with sera from control or diabetic individuals. Polypeptides im-
munoprecipitated were analyzed by SDS-PAGE and autoradiography.
from diabetic patients contain distinct antibody specificities
that bind to the different tryptic fragments .
Antibodies to the 50-kD polypeptide were detected in 22
of 27 (81%) of the diabetic patients, whereas 21 of 27 (78%)
were positive for antibodies to the 37- or 40-kD fragments.
Since the antibody activities were distinct, 25 of 27 (93%)
of the diabetic patients were found to possess antibodies that
immunoprecipitate at least one of the polypeptide fragments .
None of the control individuals had antibodies to the 40-
or 37-kD components . Serum from one of the 26 controls,
a 14-yr-old girl with juvenile rheumatoid arthritis who was
persistently positive for antinuclear antibodies but negative
for rheumatoid factors, possessed antibodies to the 50-kD poly-
peptide .
Associations between Antibody Activities.
￿
Densitometric scan-
ning of bands on autoradiographs representing immunopre-
cipitated polypeptides was used to obtain a semiquantitative
estimate of amounts of antigen immunoprecipitated by in-
792
￿
Distinct 64k Autoantibodies in Diabetes
Figure 4 .
￿
Associations between antibody activities . The activities of
64k antibodies in sera from diabetic patients were analyzed by im-
munoprecipitation of the 64-kD antigen from detergent extracts of
[35S]methionine-labeled islets. Antibodies in the same sera to 50-, 40-,
and 37-kD fragments were determined by immunoprecipitation from
trypsin-treated particulate fractions of islets. Immunoprecipitated poly-
peptides were visualized by SDS-PAGE and autoradiography and
quantified by densitometric scanning of autoradiograms, expressing
results relative to a standard diabetic serum run in each experiment .
dividual sera and allowed analyses of possible associations be-
tween antibody activities. Comparison of antibodies im-
munoprecipitating the 50-kD trypsin-solubilized polypeptide
with 64k antibodies demonstrated a significant (r = 0.692,
p < 0.001) association between these two specificities (Fig .
4 a) . No significant association was found between 64k anti-
bodies and antibodies to either the 40- or 37-kD trypsin-
solubilized polypeptides (Fig. 4, b and c) . In particular, some
patients who were negative or weakly positive for 64k an-
tibodies were found to possess antibodies that immunopre-
cipitated efficiently the 37- and 40-kD trypsin-solubilized
fragments .
A strong positive correlation was observed between anti-
bodies to the 40- and 37-kD tryptic polypeptides (Fig. 4 d;
r = 0.889, p < 0.001), suggesting that the antibodies may
bind to epitope(s) common to both of these polypeptides .
No association was found between antibodies to the 50-kD
polypeptide and antibodies to either the 40- or 37-kD poly-
peptides (r = 0.124, p > 0.5 and r = 0.103, p > 0.6, respec-
tively) . The results demonstrate the presence of at least two
distinct antibody activities in Type 1 diabetic patients that
immunoprecipitate islet cell protein antigens .
10 of the diabetic patients were also analyzed for antibodies
immunoprecipitating 39-kD and 21-kD fragments released
on digestion of the islet particulate fraction at a trypsin con-
centration of 10 mg/ml . All patients positive for antibodies
to the 50-kD polypeptide also immunoprecipitated the 39-
and 21-kD fragments. Positive associations were found be-
b r.0 .317
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64k antibodies (% control) 40k antibodies (% control)tween antibodies to the 50-kD polypeptide and both the 39-
kD fragment (r = 0.869, p < 0.001) and 21-kD fragment
(r = 0.696, p < 0.025). No such association was found be-
tween antibodies to the 39-kD fragment and either the 40-
kD (r = 0.135, p > 0.7) or 37-kD (r = 0.215,p > 0.5) poly-
peptides or between antibodies to the 21-kD fragment and
the 40-kD (r = 0.104, p > 0.7) or 37-kD (r = 0.375, p >
0.2) polypeptides. These results suggest that the 39-kD and
21-kD fragments may be the products of further tryptic pro-
teolysis of the 50-kD polypeptide.
Discussion
Previous studies have shownthat the 64-kD antigen is the
only protein that is consistently and specifically immunopre-
cipitated from detergent extracts of islets by antibodies in
sera from Type 1 diabetic patients (3, 4, 8) . The 64-kD an-
tigen is a relatively minor component of islets, representing
<0.02% of total islet protein, and migrates as two compo-
nents on two dimensional gel electrophoresis (8). As a con-
sequence of the low abundance, immunoprecipitates of 64-
kD antigen may be contaminated with background proteins
that represent major cellular proteins carried nonspecifically
through the immunoprecipitation procedure (8) . Other pro-
teins recognized by individual sera (from both diabetic and
nondiabetic individuals) are occasionally found but these an-
tibody activities appear to be specific to the individual rather
than associated with disease.
As an alternative to detergent extraction of the protein from
islet membranes, proteolytic treatment of the membranes
might efficiently release fragments ofislet antigen containing
epitopes for diabetes-associated antibodies. The aim of this
studywas to identify tryptic fragments ofthe 64-kD antigen
that are recognizedby these antibodies. In our initial studies,
serum from a diabetic patient containing a high activity of
antibodies to the 64-kD antigen was used to immunoprecip-
itate the protein from detergent extracts of rat islets. The
protein immunoprecipitated by this serum migrated as a dou-
blet on the one dimensional gel system used. To identify the
major products of mild tryptic proteolysis, the 64-kD an-
tigen, isolated as an immune complex on protein A-Sepharose,
was incubated with trypsin for 30 min at 4°C. Under these
conditions, regions ofa protein involved in antibody binding,
as well as regions inaccessible to protease as a result of the
conformational folding of the molecule, are protected from
proteolytic cleavage and relatively large fragments are gener-
ated (9). Trypsin treatment ofimmunoprecipitated 64-kD an-
tigen resulted in the recovery ofthree major radiolabeled poly-
peptides of 50, 40, and 37 M
In view of the rare occurrence of islet cell proteins other
than the 64-kD antigen that are immunoprecipitated by dia-
betic patients' serum antibodies, we determined whether 64-
kD antigen-derived fragments could be recovered directly from
an islet extract prepared by treating an islet particulate frac-
tion with trypsin. Polypeptides of identical M, to those
generated by tryptic digestion ofimmunoprecipitated 64-kD
antigen were recovered from an islet extract prepared at 0.5
mg/ml trypsin. Comparison ofantibody activities in individual
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patients demonstrated a significant positive association be-
tween antibodies to the 64-kD antigen and antibodies to the
50-kD polypeptide. Antibodies immunoprecipitating 40- and
37-kD polypeptides were clearly a distinct activity, and were
not associated with antibodies to the detergent-solubilized
64-kD antigen or to the 50-kD tryptic fragment . An unex-
pected finding was that a number of patients who were nega-
tive or only weakly positive for 64k antibodies did possess
antibodies that immunoprecipitate efficiently the 40- and 37-
kD fragments from trypsin extracts. Antibodiesin these sera
did not immunoprecipitate additional proteins from deter-
gent phase-purified extracts of islets. These results suggest
that antibodies to the 40- and 37-kD tryptic fragments bind
to epitopes that are not accessible to antibodies on the
detergent-solubilized precursor but that are exposed on pro-
teolytic cleavage. The identical pattern ofbands observed after
trypsin treatment of the 64-kD antigen and after immuno-
precipitation of polypeptides from trypsin extracts of islets,
together with the rare occurrence ofdiabetes-associated anti-
body responses to other islet cell proteins, is strong evidence
that the 50-, 40-, and 37-kD tryptic fragments are derived
from the 64-kD antigen, although conclusive evidence re-
quires sequence analysis of the respective components.
The poor binding of certain antibody specificities to
detergent-solubilized antigen does not necessarily imply an
inability of antibodies to bind the native antigen on 0 cell
membranes. Solubilization of the protein by detergent ex-
traction may alter the conformation of the molecule to hinder
access of antibody to particular epitopes. However, Triton
detergents are considered to be "mild" detergents causing min-
imal denaturation ofproteins (10). Specific antibodies recog-
nizing the appropriate epitope(s) on the antigen are required
to analyze binding on membranes or intact cells. If diabetes-
associated antibodies cannot bind epitopes on native antigen,
the immune response is presumably directed mainly to a
processed form of the antigen and it is hard to envisage a
direct role of such antibodies in the destruction of pancreatic
(3 cells. Uptake and processing of the 64-kD antigen or its
fragments by infiltrating antigen-presenting cells, including
B lymphocytes that bear specific receptors for antigen and
antigen fragments, and subsequent presentation to antigen-
specific T helper cells may, nevertheless, be essential for sus-
taining an immune response to the 0 cell antigen and gener-
ating cytotoxic T cells that may mediate islet 0 cell damage.
Extraction of the islet particulate fraction at concentra-
tions of trypsin greater than 1 mg/ml resulted in reduced
yields of the 50- and 37-kD polypeptides on subsequent im-
munoprecipitation. At the higher trypsin concentrations ad-
ditional polypeptides of 39- and 21-kD were recovered. Anal-
ysis of reactivity with patients' sera suggested that both
polypeptides might be the result of further degradation of
the 50-kD polypeptide. No additional polypeptides with
similar immunoreactivity to the 37-kD polypeptide were de-
tected. Degradation of the polypeptide presumably results
either in the loss of antibody binding or in the formation
of fragments that do not contain methionine residues and,
consequently, are undetectable by the procedures used.
It is unclear whether the various fragments are derived fromthe same polypeptide chain. Although the fragments are rel-
atively large, they clearly do not share epitopes for the dis-
tinct antibody specificities detected. The polypeptides also
have the different sensitivities to trypsin degradation; the 40-
kD fragment being resistant to further trypsin digestion and
the 37-kD fragment being the most sensitive. The different
fragments are therefore likely to be derived from different
components of the 64-kD antigen.
The significance of the different antibody specificities to
fragments of the 64-kD antigen by diabetic patients is also
unclear. Differences in immune responses to regions of the
64-kD antigen may be determined by the expression of
different MHC-linked immune response genes. In view of
the strong association of Type 1 diabetes with particularMHC
haplotypes (11), it will be of interest to determine whether
possession of particular antibody reactivities by diabetic pa-
tients correlate with the MHC haplotype of those individ-
uals. The results of such an analysis may provide a link be-
tween diabetes susceptibility genes and specific immune
abnormalities associated with the disease.
93% of the diabetic patients analyzed were found to have
circulating serum antibodies to proteolytic fragments of the
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